Lb Pharmaceuticals (LBRX) Other financing activities (2025 - 2026)

Lb Pharmaceuticals' Other financing activities history runs 3 years deep, the most recent figure standing at $29000.0 for Q1 2026.

• In Q1 2026, Other financing activities changed N/A year-over-year to $29000.0; the TTM figure through Mar 2026 stood at -$327.5 million (changed N/A YoY), while the FY2025 annual figure was $247000.0, up 973.91% from the prior year.
• Other financing activities for Q1 2026 stood at $29000.0, up from -$327.5 million in the prior quarter.
• The five-year high for Other financing activities was $29000.0 in Q1 2026, with the low at -$327.5 million in Q4 2025.
• The 3-year median for Other financing activities is $23000.0 (2024), against an average of -$109.2 million.
• Peak annual rise in Other financing activities reached 1424026.09% in 2025, while the deepest fall reached 1424026.09% in 2025.
• Lb Pharmaceuticals' Other financing activities stood at $23000.0 in 2024, then sank by 1424026.09% to -$327.5 million in 2025, then soared by 100.01% to $29000.0 in 2026.
• Business Quant data shows LBRX's Other financing activities at $29000.0 in Q1 2026, -$327.5 million in Q4 2025, and $23000.0 in Q4 2024.